News stories about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cardiovascular Systems earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 46.6152460222772 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Several equities analysts have issued reports on CSII shares. Zacks Investment Research raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a report on Monday, November 13th. BidaskClub lowered Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a report on Wednesday, December 27th. William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a report on Thursday, December 21st. Needham & Company LLC lowered Cardiovascular Systems from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $33.11 to $23.00 in a report on Friday, December 15th. Finally, Raymond James Financial reaffirmed a “hold” rating on shares of Cardiovascular Systems in a report on Monday, December 4th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $27.00.
Cardiovascular Systems (NASDAQ:CSII) opened at $22.38 on Monday. The company has a current ratio of 4.65, a quick ratio of 4.13 and a debt-to-equity ratio of 0.17. Cardiovascular Systems has a twelve month low of $20.58 and a twelve month high of $33.11. The stock has a market capitalization of $743.42, a PE ratio of -223.78 and a beta of 2.32.
TRADEMARK VIOLATION NOTICE: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3223570/cardiovascular-systems-csii-earns-daily-media-impact-rating-of-0-12.html.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.